Bellicum Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial
HOUSTON, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for...
Day: December 7, 2020
MacroGenics Presents Tebotelimab Data in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma at the 2020 ASH Annual Meeting
53.8% ORR in relapsed/refractory DLBCL patients Preliminary duration of response of up to 168 days observed, with six of seven...
Agile Therapeutics Announces Nationwide Commercial Launch and Availability of Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System, a New Non-Daily, Non-Invasive Contraceptive Patch
Once-Weekly Twirla is the first and only contraceptive patch that combines levonorgestrel and ethinyl estradiol (EE) PRINCETON, N.J., Dec. 07,...
Kevin Muir Joins Delcath Systems, Inc. as VP, Commercial Operations
NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the...
Mustang Bio Announces Interim Phase 1/2 Data for MB-106 in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Data presented at the 62nd American Society of Hematology (ASH) Annual Meetingshow extremely favorable safety profile and clinical activity 89%...
Brickell Biotech Doses First Patient in Second U.S. Pivotal Phase 3 Clinical Study
Topline results from the U.S. pivotal Phase 3 program anticipated in the fourth quarter of 2021Sofpironium bromide gel, 5% (ECCLOCK®)...
Cytokinetics Announces Additional Results From GALACTIC-HF Presented at the 17th Global Cardiovascular Clinical Trialists
Supplemental Analyses of GALACTIC-HF Left: Forest plot of the primary composite endpoint for subgroups of patients with lower left ventricular...
VitalHub Subsidiary Transforming Systems Secured 5-Year Contract with NHS Herefordshire and Worcestershire CCG
TORONTO, Dec. 07, 2020 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that...
NextGen Healthcare Client Bridges Health Partners Achieves Medicare Shared Savings of Nearly $20 Million
Leveraging NextGen® Population Health Solutions, Clinically Integrated Network Improves Quality of Patient Care While Exceeding Its Savings Objectives for Two...
LivaNova Announces Board Appointment and Board Leadership Changes
LONDON--(BUSINESS WIRE)--$LIVN--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a series of enhancements to the Company’s...
Eyam Vaccines and Immunotherapeutics Reaches Agreement to License Next-Generation COVID-19 Vaccine Candidates from the University of British Columbia
VANCOUVER, BC / ACCESSWIRE / December 7, 2020 / Eyam Vaccines and Immunotherapeutics (EYAM) announced that a License Agreement has...